ECOG-ACRIN Community Cancer Research Network
Official title: ECOG-ACRIN NCORP Research Base
Funded at Ecog-Acrin Medical Research Foundation · NIH-11338030 · Data updated 2026-11-12
This program runs clinical trials and prevention projects to improve cancer care and quality of life for people treated in community clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ecog-Acrin Medical Research Foundation NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 1, 2014 |
| Project end | July 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $17,746,015 |
| NIH project number | 3UG1CA189828-11S1 |
| Project ID | NIH-11338030 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people with cancer or cancer survivors receiving care at participating community oncology sites who meet the specific eligibility for an individual trial.
✕Less likely to help
People without cancer, those not treated at participating sites, or those who do not meet individual trial eligibility are unlikely to receive direct benefit from this program.
What this research studies
You can join clinical trials sponsored by ECOG‑ACRIN at participating community oncology clinics through the NCORP network. The network tests prevention and early-detection approaches, treatment options, biomarker-guided therapies, and symptom‑management programs while collecting patient-reported outcomes and biological samples. Researchers also study treatment-related heart effects and develop behavioral and biomarker-driven interventions to improve survivorship. Trials are run at many community sites to make participation easier for people who live outside major academic centers.
Why it matters
Potential benefit: If successful, this network could speed access to better treatments, reduce treatment-related side effects, and improve quality of life for people with cancer.
How similar studies have gone: ECOG‑ACRIN and NCORP have a history of running trials that led to practice-changing results, so this network builds on an established track record.
Where this research is happening
-
Ecog-Acrin Medical Research Foundation
Philadelphia, United States Active
Researchers
- Principal investigator: Wagner, Lynne I. — Ecog-Acrin Medical Research Foundation
- Study coordinator: Wagner, Lynne I.
Related research
Other NIH-funded projects on the same topics.
-
ECOG-ACRIN NCORP Research Base overview for cancer care and prevention
A national cancer research network is running patient-centered trials and biomarker work through community sites to improve prevention, early detection, treatment, and survivorship.
-
Biorepository for Cancer Biospecimens to Advance Cancer Care
A national cancer biorepository program will securely collect, store, and share labeled tissue, blood, and other biospecimens from cancer patients to help researchers develop better tests and treatments.
-
ECOG-ACRIN cancer clinical trials network
This program runs cancer clinical trials and prevention studies to expand treatment options and improve quality of life for people with cancer and cancer survivors.
-
Support Toolkit to Boost Cancer Clinical Trial Participation
A multi-level program to help more cancer patients join NCI-supported clinical trials using a patient-friendly literacy tool and navigators.
-
Member Site Core (cancer trials network core for biomarker-driven research)
A nationwide cancer trial network core is advancing biomarker-guided therapies by linking imaging, biology, and clinical trials to improve care for adults with cancer.
-
Clinical Trials Development Core for cancer patients
A nationwide cancer research program helps develop new treatments and imaging tools to improve care for adults with cancer.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.